Thomas Eye Group

Sandy Springs, Georgia 30328

2 studies enrolling now · 13 studies all time

What they study most

Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membrane, Full-thickness Macular Holes (MH), Neovascular Age-Related Macular Degeneration (nAMD), Neovascular Age-related Macular Degeneration, Proliferative Diabetic Retinopathy, Vitreomacular Traction, Vitreomacular Traction (VMT), Vitreous Hemorrhage

Studies at this site

• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Recruiting now
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• Evaluation of Tonabersat for DME — Running, not enrolling
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed